Table 2.
Comparison of the demographic characteristics and clinical symptoms of SARS-CoV-2 in Hunan and Wuhan [7].
| Area | Hu nan | Wu han | p | reference interval |
|---|---|---|---|---|
| All patients | 28 | 41 | ||
| White blood cell count, × 10⁹ /L | 5.23 (1.95−26.68) | 6·2 (4.1–10.5) | 3.50−9.50*109/L | |
| <4 | 10/28 (35 %) | 10/40 (25 %) | 0.421 | |
| 4–10 | 14/28 (50 %) | 18/40 (45 %) | 0.806 | |
| >10 | 4/28 (15 %) | 12/40 (30 %) | 0.158 | |
| Neutrophil count, × 10⁹ /L | 3.5 (2.70−4.76) | 5.0 (3.3–8.9) | 1.80−6.30*109/L | |
| Lymphocyte count, × 10⁹/L | 0.98 (0.68−1.43) | 0.8 (0.6–1.1) | 1.10−3.20*109/L | |
| <1·1 | 17/28 (61 %) | 26/41 (63 %) | 0.509 | |
| ≥1·1 | 11/28 (39 %) | 15/41 (37 %) | 0.509 | |
| Hemoglobin, g/L | 142 (124.5−155.5) | 126.0 (118.0–140.0) | 130−175 g/L | |
| Platelet count, × 10⁹/L | 186 (157−212.75) | 164.5 (131.5–263.0) | 125−350*109/L | |
| <100 | 3/28 (11 %) | 2/40 (5%) | 0.333 | |
| ≥100 | 25/28 (89 %) | 38/40 (95 %) | 0.333 | |
| Electron spin resonance mm/h | 10 (6−18) | —— | ≤20 mm/h | |
| D-dimer, μg/mL | 0.92 (0.8−1.11) | 0.5 (0.3–1.3) | 0−0.55 μg/mL | |
| Albumin, g/L | 44.4 (42.28−46.68) | 31.4 (28.9–36.0) | 40.0−55.0 g/L | |
| Alanine amino transferase, U/L | 28.85 (22.68−41.25) | 32.0 (21.0–50.0) | 9.0−50.0 U/L | |
| Aspartate amino transferase, U/L | 30.95 (22.7−42.53) | 34.0 (26.0–48.0) | 15.0−40.0 U/L | |
| ≤40 | 11/16 (69 %) | 26/41 (63 %) | 0.478 | |
| >40 | 5/16 (31 %) | 15/41 (37 %) | 0.478 | |
| Total bilirubin, umol/L | 73.15 (72.22−79.18) | 11.7 (9.5–13.9) | 3.4−17.1 umol/L | |
| Potassium, mmol/L | 3.97 (3.65−4.31) | 4.2 (3.8–4.8) | 3.50−5.30 mmol/L | |
| Creatinine, μmol/L | 80.6 (56.5−93) | 74.2 (57.5–85.7) | 44.0−133.0 μmol/L | |
| ≤133 | 14/15 (50 %) | 37/41 (90 %) | 0.594 | |
| >133 | 1/15 (50 %) | 4/41 (10 %) | 0.594 | |
| Uric acid, umol/L | 348.9 (268.8−459.6) | —— | 208.0−428.0 μmol/L | |
| Blood Urea Nitrogen, mol/L | 4.13 (3.1−4.98) | —— | 2.90−7.14 mmol/L | |
| Creatine kinase, U/L | 120.5 (82.1−165.75) | 132.5 (62.0–219.0) | 50.0−310.0 U/L | |
| ≤185 | 14/17 (93 %) | 27/40 (68 %) | 0.209 | |
| >185 | 3/17 (7%) | 13/40 (33 %) | 0.209 | |
| Lactate dehydrogenase, U/L | 254.3 (218.25−315.8) | 286.0 (242.0–408.0) | 120.0−250.0 U/L | |
| ≤245 | 6/13 (46 %) | 11/40 (28 %) | 0.400 | |
| >245 | 7/13 (54 %) | 29/40 (73 %) | 0.400 | |
| Procalcitonin, ng/mL | 0.074 (0.044−0.090) | 0.1 (0.1–0.4) | 0−0.050 ng/mL | |
| C-reactive protein mg/L | 5.23 (1.95−26.68) | —— | ≤10.00 mg/L | |
| Respiratory tract(Ct) | 32.77 (26.3–36.9) | 32.2 (31.0–34.5) | ≤37 | |
| Rtool(Ct) | 34.64 (28.59–36.0) | —— | ≤37 | |
| Mycoplasma pneumoniae IgM | negative | —— | negative |
The clinical and laboratory data of patients in the Wuhan area originated from the article of Huang, C et al [7]. Data are median (IQR), n (%), or n/N (%), where N is the total number of patients with available data. p values comparing Hunan and Wuhan are from χ² test, Fisher’s exact test, or Mann-Whitney U test